nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—DRD2—Gilles de la Tourette syndrome	0.93	1	CbGaD
Cinnarizine—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.0033	0.0875	CbGpPWpGaD
Cinnarizine—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00321	0.085	CbGpPWpGaD
Cinnarizine—CACNA1I—brain—Gilles de la Tourette syndrome	0.00253	0.0939	CbGeAlD
Cinnarizine—Diphenylpyraline—SLC6A3—Gilles de la Tourette syndrome	0.00233	0.428	CrCbGaD
Cinnarizine—CACNA1G—nervous system—Gilles de la Tourette syndrome	0.00226	0.0842	CbGeAlD
Cinnarizine—CACNA1G—central nervous system—Gilles de la Tourette syndrome	0.00218	0.081	CbGeAlD
Cinnarizine—Benzatropine—SLC6A3—Gilles de la Tourette syndrome	0.00179	0.329	CrCbGaD
Cinnarizine—CACNA1G—brain—Gilles de la Tourette syndrome	0.00173	0.0643	CbGeAlD
Cinnarizine—HRH4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00159	0.0421	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00154	0.0408	CbGpPWpGaD
Cinnarizine—CACNA1H—nervous system—Gilles de la Tourette syndrome	0.00148	0.0551	CbGeAlD
Cinnarizine—HRH4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00144	0.0381	CbGpPWpGaD
Cinnarizine—Modafinil—SLC6A3—Gilles de la Tourette syndrome	0.00132	0.243	CrCbGaD
Cinnarizine—CACNA1D—nervous system—Gilles de la Tourette syndrome	0.00122	0.0455	CbGeAlD
Cinnarizine—CACNA1D—central nervous system—Gilles de la Tourette syndrome	0.00118	0.0438	CbGeAlD
Cinnarizine—CACNA1H—brain—Gilles de la Tourette syndrome	0.00113	0.0421	CbGeAlD
Cinnarizine—CACNA1C—nervous system—Gilles de la Tourette syndrome	0.00113	0.042	CbGeAlD
Cinnarizine—CACNA1C—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0404	CbGeAlD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00105	0.0278	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00102	0.027	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00101	0.0267	CbGpPWpGaD
Cinnarizine—CACNA1D—brain—Gilles de la Tourette syndrome	0.000935	0.0347	CbGeAlD
Cinnarizine—CACNA1C—brain—Gilles de la Tourette syndrome	0.000863	0.0321	CbGeAlD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000856	0.0227	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000841	0.0223	CbGpPWpGaD
Cinnarizine—HRH4—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000839	0.0222	CbGpPWpGaD
Cinnarizine—CYP2A6—brain—Gilles de la Tourette syndrome	0.000838	0.0311	CbGeAlD
Cinnarizine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00083	0.0309	CbGeAlD
Cinnarizine—HRH4—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000815	0.0216	CbGpPWpGaD
Cinnarizine—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00073	0.0193	CbGpPWpGaD
Cinnarizine—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000726	0.0192	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000717	0.019	CbGpPWpGaD
Cinnarizine—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000709	0.0188	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000696	0.0184	CbGpPWpGaD
Cinnarizine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000683	0.0254	CbGeAlD
Cinnarizine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000657	0.0244	CbGeAlD
Cinnarizine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000648	0.0172	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000614	0.0163	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000603	0.016	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000596	0.0158	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000585	0.0155	CbGpPWpGaD
Cinnarizine—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.000568	0.0211	CbGeAlD
Cinnarizine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000552	0.0205	CbGeAlD
Cinnarizine—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.000547	0.0203	CbGeAlD
Cinnarizine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000545	0.0144	CbGpPWpGaD
Cinnarizine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000539	0.02	CbGeAlD
Cinnarizine—HRH4—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000532	0.0141	CbGpPWpGaD
Cinnarizine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.000531	0.0198	CbGeAlD
Cinnarizine—DRD2—brain—Gilles de la Tourette syndrome	0.000522	0.0194	CbGeAlD
Cinnarizine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000519	0.0193	CbGeAlD
Cinnarizine—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000462	0.0123	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000454	0.012	CbGpPWpGaD
Cinnarizine—CYP1A1—brain—Gilles de la Tourette syndrome	0.000434	0.0161	CbGeAlD
Cinnarizine—CYP2B6—brain—Gilles de la Tourette syndrome	0.000422	0.0157	CbGeAlD
Cinnarizine—HRH1—brain—Gilles de la Tourette syndrome	0.000412	0.0153	CbGeAlD
Cinnarizine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00041	0.0152	CbGeAlD
Cinnarizine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000395	0.0147	CbGeAlD
Cinnarizine—HRH4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000393	0.0104	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000389	0.0103	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000382	0.0101	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000381	0.0101	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000355	0.00941	CbGpPWpGaD
Cinnarizine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000314	0.0117	CbGeAlD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000312	0.00828	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000303	0.00803	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—MET—Gilles de la Tourette syndrome	0.000284	0.00753	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000282	0.00748	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000238	0.0063	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000231	0.00612	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000215	0.0057	CbGpPWpGaD
Cinnarizine—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000213	0.00564	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—MET—Gilles de la Tourette syndrome	0.00021	0.00555	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—MET—Gilles de la Tourette syndrome	0.000203	0.00538	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000203	0.00537	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000198	0.00524	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—HDC—Gilles de la Tourette syndrome	0.000186	0.00493	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—MET—Gilles de la Tourette syndrome	0.000172	0.00456	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000172	0.00456	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000167	0.00443	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000163	0.00433	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000152	0.00402	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000151	0.00399	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—MET—Gilles de la Tourette syndrome	0.00015	0.00396	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000147	0.00391	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000145	0.00384	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000141	0.00373	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—MET—Gilles de la Tourette syndrome	0.00014	0.0037	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000138	0.00367	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000137	0.00362	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000134	0.00356	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000134	0.00356	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00013	0.00346	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000125	0.00332	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000123	0.00326	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—MET—Gilles de la Tourette syndrome	0.000123	0.00326	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000122	0.00323	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000122	0.00322	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000121	0.0032	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000119	0.00314	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000118	0.00314	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000117	0.00311	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000115	0.00305	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000113	0.003	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00011	0.00292	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000107	0.00284	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000101	0.00269	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—MET—Gilles de la Tourette syndrome	9.98e-05	0.00264	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.19e-05	0.00244	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	9.17e-05	0.00243	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.03e-05	0.00239	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.92e-05	0.00236	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.92e-05	0.00236	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—MET—Gilles de la Tourette syndrome	8.77e-05	0.00232	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.76e-05	0.00232	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.76e-05	0.00232	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	8.51e-05	0.00226	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.16e-05	0.00216	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	7.73e-05	0.00205	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.65e-05	0.00203	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.51e-05	0.00199	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	7.4e-05	0.00196	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.21e-05	0.00191	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7e-05	0.00185	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	6.83e-05	0.00181	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.52e-05	0.00173	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.82e-05	0.00154	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.72e-05	0.00151	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.2e-05	0.00138	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	5.14e-05	0.00136	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.1e-05	0.00135	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	5.1e-05	0.00135	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.04e-05	0.00134	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.95e-05	0.00131	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.72e-05	0.00125	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.63e-05	0.00123	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.61e-05	0.00122	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.58e-05	0.00121	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.57e-05	0.00121	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.00119	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.36e-05	0.00115	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.19e-05	0.00111	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.29e-05	0.000872	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.23e-05	0.000856	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000792	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.93e-05	0.000777	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000738	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.74e-05	0.000725	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000717	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.66e-05	0.000704	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.47e-05	0.000656	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000468	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.73e-05	0.000459	CbGpPWpGaD
